International Flavors & Fragrances IFF Health & Biosciences — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by International Flavors & Fragrances in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: International Flavors & Fragrances’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about International Flavors & Fragrances's health & biosciences — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is International Flavors & Fragrances's health & biosciences — net sales?
- International Flavors & Fragrances (IFF) reported health & biosciences — net sales of $595M in Q1 2026.
- How has International Flavors & Fragrances's health & biosciences — net sales changed year-over-year?
- International Flavors & Fragrances's health & biosciences — net sales increased by 10.2% year-over-year, from $540M to $595M.
- What is the long-term trend for International Flavors & Fragrances's health & biosciences — net sales?
- Over 4 years (2021 to 2025), International Flavors & Fragrances's health & biosciences — net sales has grown at a -0.5% compound annual growth rate (CAGR), from $2.33B to $2.28B.
- What does health & biosciences — net sales mean?
- The total revenue generated from the sale of goods and services within the Health & Biosciences segment, net of returns, allowances, and discounts. This metric reflects the market demand for the segment's specialty ingredients and proprietary formulations.